Mohsen Nabi-Afjadi

10PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer cell biologyCardiology (incl. cardiovascular diseases)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 04, 2025
Novel receptor tyrosine kinase-targeted strategies to overcome resistance in oral squamous cell carcinoma.

Shahryar Irannejadrankouhi, Hassan Mivehchi, Aisan Eskandari-Yaghbastlo

|Dec 02, 2024
The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors.

Mahsa Liaghat, Saeid Ferdousmakan, Seyedeh Haniyeh Mortazavi

|Apr 09, 2024
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights.

Ahmadreza Lagzian, Marziye Askari, Melika Sadat Haeri

|Feb 15, 2024
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches.

Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi

|Oct 12, 2022
Current understanding of epigenetics role in melanoma treatment and resistance.

Mohsen Karami Fath, Ali Azargoonjahromi, Asma Soofi

|Oct 04, 2022
The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment.

Hanieh Fahmideh, Hooriyeh Shapourian, Rasol Moltafeti

Pageof 2

Frequent Collaborators

5 joint publications

Hamidreza Zalpoor

2 joint publications

Zahra Payandeh

1 joint publications

Dariush Shanehbandi

1 joint publications

Farhad Seif